📰 Technology Platform News
Page 145 - Technology Platform News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technology Platform. Real-time updates on events, politics, business and more.
April 13, 2023
Lewisville, TX (PRWEB) April 13, 2023 -- Semos Cloud unrolls product innovation for three of its solutions, JobPts - Culture & Recognition, Nurture - Employee
April 13, 2023
REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) shares traded up 7.5% on Thursday . The company traded as high as $19.21 and last traded at $19.05. 70,883 shares changed hands during trading, a decline of 83% from the average session volume of 416,901 shares. The stock had previously closed at $17.72. Analysts Set New Price Targets […]
April 13, 2023
Triumph Capital Management increased its stake in SoFi Technologies, Inc. (NASDAQ:SOFI – Get Rating) by 4.7% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 312,943 shares of the company’s stock after purchasing an additional 14,086 shares during the period. SoFi Technologies makes up 0.8% of […]
April 11, 2023
/PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for RGX-202,...
April 6, 2023
REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) reached a new 52-week low during trading on Thursday . The stock traded as low as $17.82 and last traded at $18.06, with a volume of 24770 shares changing hands. The stock had previously closed at $18.17. Wall Street Analysts Forecast Growth A number of research analysts have weighed […]
April 4, 2023
EQS-News: Heidelberg Pharma AG / Key word: Conference Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Technology Platform at AACR Annual Meeting 2023... | April 4, 2023
April 4, 2023
EQS-News: Heidelberg Pharma AG / Key word(s): Conference Heidelberg Pharma Presents New Preclinical Data from its Proprietary ATAC Te...
April 4, 2023
REGENXBIO Inc. (NASDAQ:RGNX – Get Rating) has earned a consensus rating of “Moderate Buy” from the nine brokerages that are covering the stock, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The average 1-year price target among analysts […]
April 3, 2023
PREPLEX project is part of broader InfectoGnostics Research Campus in Jena, GermanyTotal project volume of PREPLEX collaborative research is approximately $ 0.9 Mio ROCKVILLE, Md., April 03,... | April 3, 2023
April 3, 2023
VGI Partners Global Investments Limited, an investment management company, released its 2022 annual investor letter. A copy of the same can be downloaded here.